EVALUATION OF THE EFFECT AND SAFETY OF PONATINIB AS THIRD LINETREATMENT FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
Conference paper > Unpublished · 2016
Authors: PÜSEM PATIR, Ayşe Uysal, Mustafa Duran, Nur SOYER, Filiz VURAL, Güray SAYDAM
AHOS 2016, International, Verbal, Unpublished, 2016-2016, vol 1, pp 34-